reuters dr scott gottlieb president donald trump ’s nominee lead us food drug administration outline measure -PRON- would take untangle -PRON- tie pharmaceutical industry confirm senate
ethic disclosure form file department health human service tuesday gottlieb say -PRON- would resign multiple corporate board include glaxosmithkline plc consulting position
gottlieb ’s financial tie healthcare industry extensive
confirm -PRON- agree recuse -PRON- matter -PRON- financial interest div -PRON- holding 20 mostly small healthcare company
gottlieb 44 widely expect confirm though -PRON- pharmaceutical tie likely scrutinize democrats
past decade -PRON- partner new enterprise associate large venture capital fund investment life sciences
-PRON- would also resign -PRON- position investment firm tr
winston co say -PRON- would perform consulting work run agency participate matter involve previous client year last provide service client
gottlieb resident fellow conservative american enterprise institute think tank view favorably drug industry
-PRON- would responsible implement key element recently pass 21st century cure act call agency streamline drug approval process